mRNA Vaccines and Therapeutics Global Market Report 2023: Sector to Reach $66.2 Billion by 2028 at a 2.8% CAGR –

mRNA Vaccines and Therapeutics Global Market Report 2023: Sector to Reach $66.2 Billion by 2028 at a 2.8% CAGR –

mRNA Vaccines and Therapeutics Global Market Report 2023: Sector to Reach $66.2 Billion by 2028 at a 2.8% CAGR –

DUBLIN–(BUSINESS WIRE)–The “mRNA Vaccines and Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” report has been added to’s offering.

The global mRNA vaccines and therapeutics market size reached US$ 56.1 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 66.2 Billion by 2028, exhibiting a CAGR of 2.8% during 2022-2028.

The rising prevalence of medical ailments, such as diabetes, tuberculosis, cancer and cardiovascular diseases (CVDs), is one of the key factors driving the growth of the market. The increasing demand for therapeutic medicines and vaccines for Ebola, influenza, Human Immunodeficiency Virus (HIV) and other viral infections is also providing a boost to the market growth.

In comparison to conventional medicines, mRNA vaccines and therapeutics are developed using advanced technologies that are more effective against pathogens, have higher potency, enhanced immunogenicity and are relatively more cost-effective.

Additionally, improvements in the lipid nanoparticle formulations for in-vivo systemic delivery of mRNA are also creating a positive outlook for the market. Pharmaceutical companies are investing in mRNA technologies as they can combine multiple molecules into a therapeutic medicine, which is acting as another major growth-inducing factor.

Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with improvements in the healthcare technologies, are projected to drive the market further.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global mRNA vaccines and therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on vaccine type, treatment type, vaccine manufacturing, application and end-user.

Breakup by Vaccine Type:

  • Self-amplifying mRNA-Based Vaccines
  • Conventional Non-Amplifying mRNA-Based Vaccines

Breakup by Treatment Type:

  • Bioengineered Vaccine
  • Gene Therapy
  • Gene Transcription
  • Cell Therapy
  • Monoclonal Antibody
  • Others

Breakup by Vaccine Manufacturing:

  • In-House
  • Out-Sourced

Breakup by Application:

  • Cancer
  • Infectious Disease
  • Gene Editing
  • Protein Replacement

Breakup by End-User:

  • Hospitals and Clinics
  • Research Organizations
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Introduction to mRNA Vaccines and Therapeutics

5.1 History of mRNA Vaccines and Therapeutics Development

5.2 Incidence and Prevalence of Chronic Diseases and Major Infectious Diseases

5.3 Prevention and Treatment Using mRNA Vaccines and Therapeutics

5.3.1 mRNA Modifications

5.3.2 mRNA Efficiencies

5.3.3 Adjuvant/Stimulant and Carrier Technologies for mRNA-Based Vaccines

5.3.4 Carriers for mRNA-Based Protein and Antibody Therapeutics

6 Global mRNA Vaccines and Therapeutics Market

7 Market Breakup by Vaccine Type

8 Market Breakup by Treatment Type

9 Market Breakup by Vaccine Manufacturing

10 Market Breakup by Application

11 Market Breakup by End-User

12 Market Breakup by Region

13 SWOT Analysis

14 Value Chain Analysis

15 Porters Five Forces Analysis

16 Competitive Landscape

Companies Mentioned

  • Arcturus Therapeutics Inc.
  • BioNTech SE
  • CureVac AG
  • eTheRNA immunotherapies NV
  • ethris GmbH
  • GlaxoSmithKline PLC
  • Moderna Therapeutics Inc.
  • Translate Bio Inc.
  • Argos Therapeutics
  • Inc.
  • Sangamo Therapeutics Inc.
  • Pfizer Inc

For more information about this report visit

About is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900